48 results on '"Coello, Klara"'
Search Results
2. Inflammatory and oxidative stress biomarkers in children and adolescents with bipolar disorder – A systematic review and meta-analysis
3. A composite immune and vascular stress marker in patients newly diagnosed with bipolar disorder and their unaffected first-degree relatives
4. Socio-economic status, functioning and cognition in young versus adult patients newly diagnosed with bipolar disorder and their unaffected relatives; results from a cross-sectional study
5. Differences in clinical presentation between newly diagnosed bipolar I and II disorders: A naturalistic study
6. Predictors of mood and activity instability in participants with newly diagnosed bipolar disorder – Exploratory findings from a prospective cohort study
7. Personality disorders in patients with newly diagnosed bipolar disorder, their unaffected first-degree relatives and healthy control individuals
8. Persistent increase over time in oxidatively stress generated RNA and DNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives – An up to 5-year prospective study
9. Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study
10. Associations between levels of oxidative nucleoside damage and cardiovascular risk in patients newly diagnosed with bipolar disorder and their unaffected relatives
11. Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review.
12. Struggling Can Also Show on the Inside: Current Knowledge of the Impact of Childhood Maltreatment on Biomarkers in Mood Disorderss
13. Affective disorders impact prevalence of Flavonifractor and abundance of Christensenellaceae in gut microbiota
14. Mood, activity, and sleep measured via daily smartphone-based self-monitoring in young patients with newly diagnosed bipolar disorder, their unaffected relatives and healthy control individuals
15. Affective and non-affective cognition in patients with bipolar disorder type I and type II in full or partial remission: Associations with familial risk
16. Mood instability in patients with newly diagnosed bipolar disorder, unaffected relatives, and healthy control individuals measured daily using smartphones
17. Oxidation of DNA and RNA in young patients with newly diagnosed bipolar disorder and relatives
18. Impact of modification to DSM-5 criterion A for hypomania/mania in newly diagnosed bipolar patients: findings from the prospective BIO study
19. Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
20. Hair cortisol in newly diagnosed bipolar disorder and unaffected first-degree relatives
21. Sleep and physical activity in patients with newly diagnosed bipolar disorder in remission, their first-degree unaffected relatives and healthy controls
22. Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
23. Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
24. Socio-economic status and functioning in patients newly diagnosed with bipolar disorder and their unaffected siblings - Results from a cross-sectional clinical study
25. Dyslipidæmi ved psykisk lidelse
26. Associations between childhood maltreatment and oxidative nucleoside damage in affective disorders
27. Prevalences of comorbid anxiety disorder and daily smartphone-based self-reported anxiety in patients with newly diagnosed bipolar disorder
28. Association between lifetime and recent stressful life events and the early course and psychopathology in patients with newly diagnosed bipolar disorder, first‐degree unaffected relatives and healthy controls: Cross‐sectional results from a prospective study
29. Higher systemic oxidatively generated DNA and RNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
30. Brain-derived neurotrophic factor levels in newly diagnosed patients with bipolar disorder, their unaffected first-degree relatives and healthy controls
31. Impact of Modification to DSM-5 Criterion A for Hypomania/Mania in Newly Diagnosed/First Episode Bipolar Patients – Findings From the Prospective BIO Study
32. Association between lifetime and recent stressful life events and the early course and psychopathology in patients with newly diagnosed bipolar disorder, first‐degree unaffected relatives and healthy controls: Cross‐sectional results from a prospective study
33. Associations between childhood maltreatment and oxidative nucleoside damage in affective disorders.
34. Mood, activity, and sleep measured via daily smartphone-based self-monitoring in young patients with newly diagnosed bipolar disorder, their unaffected relatives and healthy control individuals
35. High-sensitive C-reactive protein and homocysteine levels in patients with newly diagnosed bipolar disorder, their first-degree relatives, and healthy control persons—Results from a clinical study
36. MOESM1 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
37. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives
38. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
39. Thirty-year cardiovascular risk in patients with newly diagnosed bipolar disorder and their healthy first-degree relatives
40. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives.
41. Postprandial prolactin suppression appears absent in antipsychotic-treated male patients
42. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives.
43. Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI study.
44. MOESM2 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
45. MOESM2 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
46. Longitudinal changes in resting-state functional connectivity as markers of vulnerability or resilience in first-degree relatives of patients with bipolar disorder.
47. [Dyslipidaemia in patients with mental illness].
48. Prevalences of comorbid anxiety disorder and daily smartphone-based self-reported anxiety in patients with newly diagnosed bipolar disorder.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.